2023-05-03 09:00:00〜2023-05-03 10:00:00の英語タイムライン672件の要約ですわ。

・Early results from a Phase 1/2 trial of a COVID-19 vaccine developed by Oxford University have shown it is safe and triggers an immune response.

・The vaccine is called ChAdOx1 nCoV-19 and uses a harmless virus to deliver genetic material from the coronavirus to the body's cells.

・The trial involved 1,077 healthy volunteers aged 18 to 55.

・The vaccine stimulated the production of both antibodies and T-cells.

・More research is needed to determine the vaccine's effectiveness and success.

・The UK government has already ordered 100 million doses of the vaccine.

・Production began before the trial's results were known.

・The researchers caution that there are no guarantees the vaccine will be successful.

・The vaccine's safety and immune response are positive signs in the fight against COVID-19.

・This vaccine is a promising development in the ongoing effort to combat the coronavirus.

#summary4en2ja #exceptsummary